Wednesday, March 10, 2010

LDN and MS, CFS, fibromyalgia

*Note:* Low Dose Naltrexone (LDN) has proven effective for some patients in
a number of diseases including MS, CFS and fibromyalgia. Two members of the
About.com community have written about LDN. On the Multiple Sclerosis blog
by Julie Stachowiak, Ph.D. she said she began LDN after "... couple of bad
relapses, none since starting Copaxone, but *worsening, horrible, awful,
brain-numbing **MS-related
fatigue<http://ms.about.com/od/signssymptoms/a/fatigue_over.htm>
*, which is driving me to do *something*."
http://ms.about.com/b/2009/04/21/julies-low-dose-naltrexone-journal-preparation.htm
Journalist Adrienne Dwello on About.com: Fibromyalgia & CFS has also written
about LDN.

http://chronicfatigue.about.com/od/treatingfmscfs/p/LDN.htm

2010 European LDN Conference: LDN can be used as effective treatment for
people with MS 10. March 2010 03:09

People with MS (Multiple
Sclerosis<http://www.news-medical.net/health/Multiple-sclerosis-%28MS%29.aspx>)
and others suffering with a range of often debilitating inflammatory
conditions such as Chronic Fatigue
Syndrome<http://www.news-medical.net/health/What-is-Chronic-Fatigue-Syndrome.aspx>and
Fibromyalgia, will take heart from advances in treatment for their
conditions, and will follow events at The 2nd European LDN Conference with
interest.

"Following the success of last year's inaugural conference, we are returning
to Glasgow. There have been a number of important developments in the past
year and this year's conference is set to be a landmark event."

Taking place in Glasgow on 24th April, 2010 at the Thistle Hotel in
Cambridge Street, The 2010 European LDN conference is again organised by Dr
Tom Gilhooly of the Essential Health Clinic in Glasgow with support from
Linda Elsegood and the LDN Research Trust. According to Dr Gilhooly,
"Following the success of last year's inaugural conference, we are returning
to Glasgow. There have been a number of important developments in the past
year and this year's conference is set to be a landmark event." The
conference is sponsored and supported online by BIG ON Glasgow.

LDN – Low Dose Naltrexone – was initially developed as a treatment in the
United States in the 1980s. Working with opiate addicted patients, it was
realised that in low doses, Naltrexone could actually be used to increase
endorphin levels, effective in the treatment of MS. It was first used as a
treatment for MS in 1985.

As an MS sufferer, Linda Elsegood spent two years bed-bound until treatment
with LDN enabled her to regain the use of her motor skills. She set up the
charity LDN Research Trust with the aim of increasing awareness and to raise
funds for clinical trials. The LDN Research Trust has a database of over
3,000 people using LDN treatments in the UK.

As one of the small number of practices administering LDN in the UK, Dr
Gilhooly and his fellow GPs at The Essential Health Clinic are hoping to
raise the profile of LDN. Dr Gilhooly comments "LDN treatment can aid a
better quality of life for both long-term sufferers and those newly
diagnosed. I hope the conference will result in many more patients becoming
aware that this could be a treatment for them."

The conference will attract leading medical professionals and patients
interested in the use of LDN in several conditions including Multiple
Sclerosis<http://www.news-medical.net/health/Multiple-sclerosis-%28MS%29.aspx>,
Chronic Fatigue
Syndrome<http://www.news-medical.net/health/What-is-Chronic-Fatigue-Syndrome.aspx>and
Fibromyalgia, Crohn's Disease, IBS, Parkinson's Disease and
Autism <http://www.news-medical.net/health/What-is-Autism.aspx>
among
others. Dr Jarred Younger of Stanford University will present some of his
exciting findings on the use of LDN in Fibromyalgia and will highlight
several patient testimonies on the subject.

The conference will also look at the relationship between LDN and CCSVI, the
new vascular disorder causing much excitement in the world of MS. Where
CCSVI fits in with LDN in the treatment of MS and other auto-immune
disorders will be the centre of discussion and debate.

SOURCE Cision
http://www.news-medical.net/news/20100310/2010-European-LDN-Conference-LDN-can-be-used-as-effective-treatment-for-people-with-MS.aspx





2 comments:

Bioveda said...

Here is another article about Fibromyalgia that discusses chiropractic care for relief. Hope it helps!

CFS Facts said...

I can also vouch for chiropractic as helpful. With just the first treatment, I went from being able to do 5 minutes housework total per day to 10 minutes total.

And it helped the pain, too.